Study Protocol - Accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR Study
- Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria. Lin, Jennie; Reilly, Muredach P.; Terembula, Karen; Wilson, F. Perry // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1
Background: CKD, an independent risk factor for CV disease, increases mortality in T2DM. Treating modifiable CV risk factors decreases mortality in diabetics with microalbuminuria, but the role of early CV prevention in diabetics with mild CKD by GFR criteria alone remains unclear. The purpose...
- Prevalencia de hiperhomocisteinemia en un grupo de pacientes con diagnÃ³stico de diabetes mellitus tipo 2 en el estado de YucatÃ¡n, MÃ©xico. Sansores, Carlos J. Castro; Perera, Dora M. Lara; Rodríguez, Francisco Solís // Medicina Interna de Mexico;may/jun2010, Vol. 26 Issue 3, p207
No abstract available.
- Reducing Cardiovascular Complications of Type 2 Diabetes. Savage, Peter J.; Narayan, K.M. Venkat // Diabetes Care;Nov99, Vol. 22 Issue 11, p1769
Editorial. Focuses on how to reduce cardiovascular complications of type 2 diabetes. Relationship between microvascular complications and the degree of glucose control in both type 1 and 2 diabetes; Reduction of hospital utilization for cardiovascular diseases by simvastatin therapy; Economic...
- HEALTH MATTERS. EARLY TREATMENT OF TYPE 2 DIABETES MAY REDUCE HEART DISEASE RISK. // Today's Dietitian;Aug2015, Vol. 17 Issue 8, p55
No abstract available.
- Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition. McKeown-Eyssen, Gail; Hanley, Anthony J. G.; Harris, Stewart B.; Hegele, Robert A.; Wolever, Thomas M.S.; Kwan, Jeremy; Connelly, Philip W.; Zinman, Bernard // Diabetes Care;Jul2001, Vol. 24 Issue 7, p1240
Presents a study which examined cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors using data from a sample population of type 2 diabetics in a Native Canadian community. Research design and methods; Results; Conclusions.
- FIELD: Fenofibrate reduced CVD risk among patients with type 2 diabetes, metabolic syndrome. // Cardiology Today;Apr2009, Vol. 12 Issue 4, p1
The article discusses research which found that patients with type 2 diabetes and metabolic syndrome had the greatest five-year-risk for cardiovascular disease and were likely to reap the greatest benefits from fenofibrate treatment.
- CV Event Risk Lower with Metformin. STEIN, JILL // Renal & Urology News;Sep2011, Vol. 10 Issue 9, p1
The article reports on the findings of a study conducted by Alex Z. Fu and colleagues which reveals that older patients with type 2 diabetes have a significantly lower likelihood of experiencing a cardiovascular (CV) event within two years if they start a treatment with metformin.
- Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. Khan, Alam; Safdar, Mahpara; Khan, Mohammad Muzaffar Ali; Khattak, Khan Nawaz; Anderson, Richard A. // Diabetes Care;Dec2003, Vol. 26 Issue 12, p3215
OBJECTIVE â€” The objective of this study was to determine whether cinnamon improves blood glucose, triglyceride, total cholesterol, HDL cholesterol, and LDL cholesterol levels in people with type 2 diabetes. RESEARCH DESIGN AND METHODS â€” A total of 60 people with type 2 diabetes, 30...
- Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes. Masding, Michael G.; Stears, Anna J.; Burdge, Graham C.; Wootton, Stephen A.; Sandeman, Derek D. // Diabetes Care;Dec2003, Vol. 26 Issue 12, p3243
OBJECTIVE â€” Women with type 2 diabetes appear to lose the protection against cardiovascular disease afforded by estrogens. We examined the effects of menopausal status on postprandial clearance of dietary fat in healthy and diabetic women. RESEARCH DESIGN AND METHODS â€” Fasting...